These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11493292)

  • 21. Full-face treatment with onabotulinumtoxinA: Results from a single-center study.
    D'Emilio R; Rosati G
    J Cosmet Dermatol; 2020 Apr; 19(4):809-816. PubMed ID: 31486568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of botulinum toxin type a on tear production after treatment of lateral canthal rhytids.
    Arat YO; Yen MT
    Ophthalmic Plast Reconstr Surg; 2007; 23(1):22-4. PubMed ID: 17237684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Festoon formation after infraorbital botulinum A toxin: a case report.
    Goldman MP
    Dermatol Surg; 2003 May; 29(5):560-1; discussion 561. PubMed ID: 12752529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alteration of Skin Mechanical Properties in Patients Undergoing Botulinum Toxin Type A Injections of Forehead Rhytides.
    Min P; Zhang Z; Grassetti L; Perdanasari AT; Torresetti M; Pu Z; Zhang Y; Han S; Marsili R; Zhang YX; di Benedetto G; Lazzeri D
    Aesthetic Plast Surg; 2016 Jun; 40(3):410-20. PubMed ID: 26944891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Botulinum Toxin A Treatment on Eyelid Pressure in Eyes with Blepharospasm.
    Namiguchi K; Mizoue S; Ohta K; Shiraishi A
    Curr Eye Res; 2018 Jul; 43(7):896-901. PubMed ID: 29641935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Anatomical studying of the tear trough area].
    Yang N; Qiu W; Wang Z; Su X; Jia H; Shi H
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2014 Jan; 30(1):50-3. PubMed ID: 24754199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New indications for botulinum toxin type A in treating facial wrinkles of the mouth and neck.
    Spósito MM
    Aesthetic Plast Surg; 2002; 26(2):89-98. PubMed ID: 12016492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modifications of eyebrow position with botulinum exotoxin A.
    Kokoska MS; Amato JB; Hollenbeak CS; Glaser DA
    Arch Facial Plast Surg; 2002; 4(4):244-7. PubMed ID: 12437430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Management of upper eyelid retraction associated with dysthyroid orbitopathy during the acute inflammatory phase with botulinum toxin type A].
    Nava Castañeda A; Tovilla Canales JL; Garnica Hayashi L; Velasco Y Levy A
    J Fr Ophtalmol; 2017 Apr; 40(4):279-284. PubMed ID: 28336282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety of onabotulinum toxin a injection to the central upper eyelid and eyebrow regions.
    Huang L; Costin BR; Sakolsatayadorn N; Perry JD
    Ophthalmic Plast Reconstr Surg; 2014; 30(5):377-80. PubMed ID: 24777259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Width of the orbicularis oculi fibers extending to the upper lip with the lateral and inferior lengths of the orbicularis oculi at the lateral canthus level: application to botulinum neurotoxin type A injection for crow's feet.
    Hur MS; Iwanaga J; Tubbs RS; Moon YS; Kim H
    Surg Radiol Anat; 2023 Apr; 45(4):461-468. PubMed ID: 36792669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The anatomical relationship between the orbicularis oculi muscle and the levator labii superioris and zygomaticus muscle complexes.
    Spiegel JH; DeRosa J
    Plast Reconstr Surg; 2005 Dec; 116(7):1937-42; discussion 1943-4. PubMed ID: 16327606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dry eye syndrome due to botulinum toxin type-A injection: guideline for prevention.
    Ozgur OK; Murariu D; Parsa AA; Parsa FD
    Hawaii J Med Public Health; 2012 May; 71(5):120-3. PubMed ID: 22737648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deep resting glabellar rhytides respond to BTX-A and Hylan B.
    Carruthers J; Carruthers A; Maberley D
    Dermatol Surg; 2003 May; 29(5):539-44. PubMed ID: 12752525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rejuvenation of periocular region in Koreans: A multimodal approach combining botulinum toxin, fillers, and micro-focused ultrasound with visualization for optimal results.
    Park JY; Byun EJ; Kim HS
    Dermatol Ther; 2020 Jan; 33(1):e13159. PubMed ID: 31697448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized, evaluator-blinded, two-center study of the safety and effect of volume on the diffusion and efficacy of botulinum toxin type A in the treatment of lateral orbital rhytides.
    Carruthers A; Bogle M; Carruthers JD; Dover JS; Arndt KA; Hsu TS; Poirier J
    Dermatol Surg; 2007 May; 33(5):567-71. PubMed ID: 17451579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term prospective follow-up of botulinum toxin treatment for facial rhytides.
    Bulstrode NW; Grobbelaar AO
    Aesthetic Plast Surg; 2002; 26(5):356-9. PubMed ID: 12432474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and efficacy of administering abobotulinumtoxinA through a single injection point when treating lateral periocular rhytides.
    Kiripolsky MG; Goldman MP
    J Cosmet Dermatol; 2011 Sep; 10(3):232-4. PubMed ID: 21896136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surgical management of functional bladder outlet obstruction in adults with neurogenic bladder dysfunction.
    Utomo E; Groen J; Blok BF
    Cochrane Database Syst Rev; 2014 May; 2014(5):CD004927. PubMed ID: 24859260
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Botulinum toxin A treatment of perioral rhytides.
    Semchyshyn N; Sengelmann RD
    Dermatol Surg; 2003 May; 29(5):490-5; discussion 495. PubMed ID: 12752516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.